Answers are grounded in this paper and cite their sources.
Observational study finds improved medication compliance with Etelcalcetide in dialysis patients, suggesting better treatment options.
3) Secondary hyperparathyroidism control can be achieved with well balanced and patient specific treatment regimens including Etelcalcetide.4) Medication compliance and concordance can be improved significantly with IV Etelcalcetide treatment on dialysis for many patients.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
No takes yet. Share an insight, caveat, or question.
Pura et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: